new_0222_0694|GRCL|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0694|GRCL|1|Gracell Biotechnologies Inc Total Current Assets (Quarterly) (USD)|Gracell Biotechnologies Inc Cash and Short Term Investments (Quarterly) (USD)|Gracell Biotechnologies Inc Inventories (Quarterly) (USD)|Gracell Biotechnologies Inc Net PP&E (Quarterly) (USD)|Gracell Biotechnologies Inc Goodwill and Intangibles (Quarterly) (USD)|Gracell Biotechnologies Inc Total Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Current Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Long Term Liabilities (Quarterly) (USD)|Gracell Biotechnologies Inc Total Deposits (Quarterly) (USD)|Gracell Biotechnologies Inc Book Value (Quarterly) (USD)|Gracell Biotechnologies Inc Retained Earnings (Quarterly) (USD)|Gracell Biotechnologies Inc Treasury Stock (Quarterly) (USD)|Gracell Biotechnologies Inc EV to Revenues|Gracell Biotechnologies Inc EV to Earnings|Gracell Biotechnologies Inc EV to Free Cash Flow|Gracell Biotechnologies Inc EV to Assets (Quarterly)|Gracell Biotechnologies Inc PS Ratio|Gracell Biotechnologies Inc PE Ratio|Gracell Biotechnologies Inc Price to Book Value|Gracell Biotechnologies Inc PEG Ratio|Gracell Biotechnologies Inc Debt to Equity Ratio|Gracell Biotechnologies Inc Dividend Yield|Gracell Biotechnologies Inc Shareholder Yield (TTM)|Gracell Biotechnologies Inc Percent of Shares Outstanding Short|Gracell Biotechnologies Inc Total Receivables (Quarterly) (USD)|Gracell Biotechnologies Inc Total Payables (Quarterly) (USD)|Gracell Biotechnologies Inc Total Capital Stock (Quarterly) (USD)|Gracell Biotechnologies Inc Return on Invested Capital|Gracell Biotechnologies Inc Quality Ratio Score|Gracell Biotechnologies Inc Momentum Score|Gracell Biotechnologies Inc Beta (1Y)|Gracell Biotechnologies Inc Sustainable Growth Rate (TTM)|Gracell Biotechnologies Inc Institutional Investor Ownership Percentage|Gracell Biotechnologies Inc Average Diluted Shares Outstanding (Quarterly)|Gracell Biotechnologies Inc Total Employees (Annual)|Gracell Biotechnologies Inc EPS Diluted (Quarterly) (USD)|Gracell Biotechnologies Inc SG&A Expense (Quarterly) (USD)|Gracell Biotechnologies Inc Shares Outstanding|Gracell Biotechnologies Inc Repurchase of Capital Stock (Quarterly) (USD)|Gracell Biotechnologies Inc Ordinary Shares Number (Quarterly)|Gracell Biotechnologies Inc Payout Ratio|Gracell Biotechnologies Inc Quick Ratio (Quarterly)|Gracell Biotechnologies Inc Normalized Diluted EPS (Quarterly) (USD)|Gracell Biotechnologies Inc Stock Buybacks (Quarterly) (USD)|Gracell Biotechnologies Inc Effective Tax Rate (TTM)|Gracell Biotechnologies Inc Return on Equity|Gracell Biotechnologies Inc Net Income (TTM) (USD)|Gracell Biotechnologies Inc Revenue (TTM) (USD)|Gracell Biotechnologies Inc Dividend Per Share (Quarterly) (USD)|Gracell Biotechnologies Inc Revenue (Quarterly) (USD)|Gracell Biotechnologies Inc Gross Profit (Quarterly) (USD)|Gracell Biotechnologies Inc Pre-Tax Income (Quarterly) (USD)|Gracell Biotechnologies Inc Net Income (Quarterly) (USD)|Gracell Biotechnologies Inc Net Interest Income (Quarterly) (USD)|Gracell Biotechnologies Inc Price (USD)|Gracell Biotechnologies Inc Total Return Price (USD)|Gracell Biotechnologies Inc Enterprise Value (USD)|Gracell Biotechnologies Inc 30-Day Average Daily Volume|Gracell Biotechnologies Inc 1 Year Price Returns (Daily)|Gracell Biotechnologies Inc Short Interest|Gracell Biotechnologies Inc PE Ratio (Forward)|Gracell Biotechnologies Inc PE Ratio (Forward 1y)|Gracell Biotechnologies Inc PS Ratio (Forward)|Gracell Biotechnologies Inc PS Ratio (Forward 1y)|Gracell Biotechnologies Inc Quarterly EPS Estimates (USD)|Gracell Biotechnologies Inc Quarterly Revenue Estimates (USD)|Gracell Biotechnologies Inc Quarterly EPS Surprise|Gracell Biotechnologies Inc Quarterly Revenue Surprise|Gracell Biotechnologies Inc Quarterly Actual EPS (USD)|Gracell Biotechnologies Inc Quarterly Actual Revenue (USD)|Gracell Biotechnologies Inc Revenue Estimates for Current Fiscal Year (USD)|Gracell Biotechnologies Inc Revenue Estimates for Next Fiscal Year (USD)|Gracell Biotechnologies Inc Price Target (USD)|Gracell Biotechnologies Inc Consensus Recommendation|Gracell Biotechnologies Inc Price Target Num Estimates|Gracell Biotechnologies Inc EPS Estimates for Current Fiscal Year (USD)|Gracell Biotechnologies Inc EPS Estimates for Next Fiscal Year (USD)|Gracell Biotechnologies Inc Research and Development Expense (Quarterly) (USD)|Gracell Biotechnologies Inc Reconciled Depreciation (Quarterly) (USD)|Gracell Biotechnologies Inc Non-Operating Interest Expense (Quarterly) (USD)|Gracell Biotechnologies Inc Land and Improvements (Quarterly) (USD)|Gracell Biotechnologies Inc Buildings and Improvements (Quarterly) (USD)|Gracell Biotechnologies Inc Other Properties (Quarterly) (USD)|Gracell Biotechnologies Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0694|GRCL|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0694|GRCL|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0694|GRCL|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||||||1.44|||1.44483985765||15.24|183|183|127.8|||||||91.2857142857|92|91.2857142857|91.2857142857|53.4|366|127.8|||91.2857142857||91.25||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.44483985765|1.44483985765|1.44483985765|1.43253968254|1.39285714286|15.24|||1.44483985765|1.44483985765|91.25|91.25|91||91|91|49.5714285714|62.8|34.5454545455|15.2|34.5454545455|23.1333333333|28.5454545455|91.2857142857|91.5|91.2857142857|||127.8|183||
new_0222_0694|GRCL|6|5|5||5||5|5|5||5|5||||||||225|||281||25|2|2|5|||||||7|1|7|7|5|1|5|||7||4||4|||||7|7|7|281|281|281|252|28|25|||281|281|8|8|3||3|3|7|5|11|25|11|15|11|7|4|7|||5|2||
new_0222_0694|GRCL|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0694|GRCL|201909|||||||||||||||||||||||||||||||||||||||-6.3716|||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0694|GRCL|201912|48.6439|45.2002||10.2709||22.4189|2.5963|19.8226||-41.8028|-41.3611||||||||||||||1.968|0.9604|78.3085|||||||19.809||-0.3829|1.1251|||327.816|||-0.3098|||||||||-6.0767|-6.0767|0.2041||||||||||||||||||||||||5.3899|0.188||||0.1602|3.0541||
new_0222_0694|GRCL|202003||||||||||||||||||||||||||||||||||19.809||-0.3087|0.8057||||||-0.2316|||||||||-4.5768|-4.5768|0.1371||||||||||||||||||||||||3.9181||0.0295||||||
new_0222_0694|GRCL|202006||||||||||||||||||||||||||||||||||19.809||-0.4492|0.9832||||||-0.3252|||||||||-6.4567|-6.4567|0.0723||||||||||||||||||||||||5.7531||0.0691||||||
new_0222_0694|GRCL|202009|31.5976|25.9988||18.2985||11.2545|4.7159|6.5386||38.6416|-67.9843||||||||||||||3.8942|0.0507|0.0211|||||||65.5632|160|-0.1518|1.182|||327.816|||-0.1065||||-24.4135|||||-7.3033|-7.3033|-0.0583||||||||||||||||||||||||5.775||0.0945|||0.351|8.352||
new_0222_0694|GRCL|202012|124.8173|118.3247||22.8799||22.2379|14.29|7.9479||-89.981|-86.3314|||||||||||||0.6694|4.739|1.855|215.4507|||||||65.5632|202|-0.2299|3.738|65.5632||327.816|||-0.1907||||-30.9442|||||-12.6074|-12.6074|-0.0529|20.72|20.72|1471.333|169109.3333||438889|||17305.344|27169.3901|-0.1||-60||-0.16||||34.5|1.25|4|-0.36|-1.1858|9.1536|1.4102|0.1214|||0.45|9.8358|22.73|
new_0222_0694|GRCL|202103|337.9449|329.6041||21.8489||29.4168|18.3866|11.0303||333.4007|-100.8334||||||||3.1046|||||1.1446|||0.0337|||||||60.8977||-0.2543|4.8949|67.2132||336.066|||-0.2536||||-41.42|||||-15.0526|-15.0526|-0.0467|15.4|15.4|722.6154|78132.6||769335|||13185.7743|20701.6656|-0.1608||68.9113||-0.05||||34.75|1.25|4|-0.9007|-1.3266|10.0849||0.1903|||21.8489||12.18|15.06
new_0222_0694|GRCL|202106|327.3844|317.6493||25.0079||33.8597|20.3969|13.4628||320.6256|-117.5394||||||||2.7264|||||1.7698|||0.0343|||||||67.2334||-0.2244|4.7086|67.2435||336.2175|||-0.2226||||-49.8552|||||-14.8919|-14.8919|0.0498|13|13|574.1051|185401.9||1190078|||11135.8662|17483.31|-0.15||73.3333||-0.04||||34.75|1.25|4|-0.6257|-1.0241|10.1014||0.2185|||25.0079||12.43|10.43
new_0222_0694|GRCL|202109|311.8934|302.4784||24.1289||34.1746|21.2134|12.9612||305.2839|-137.3981|||||1.9187|||3.0667||0.0576|||1.6233|||0.0345|||||||67.2989||-0.2934|6.6183|67.4994||337.4969||14.2588|-0.2915||||-62.5151|||0.0565||-19.9632|-19.9632|0.2928|13.87|13.87|651.3095|57506.3||1095744|||11926.3271|18724.3336|-0.05||-20||-0.06|0.057|0.0523|0.0333|33.3333|1.3333|3|-0.225|-0.355|13.6836||0.1682|||24.1289||10.7|7.74
new_0222_0694|GRCL|202112|||||||||||||||||||1.3355|||||1.9722|||||||||||||||||||||||||||||||6.04|6.04|122.7892|1023034.1333|-82.8668|1331210|||8153.9275|177.2593|-0.2||||||0.0785|0.05|33.3333|1.3333|3|-0.655|-1.025||||||||3.55|3.47
new_0222_0694|GRCL|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.24|||||||||||||||||||||
new_0222_0694|GRCL|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.245|||||||||||||||||||||
new_0222_0694|GRCL|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.26|||||||||||||||||||||
new_0222_0694|GRCL|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.28|||||||||||||||||||||